PTHS
Pelthos Therapeutics Inc.

869
Loading...
Loading...
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Pelthos Therapeutics Inc.?
What is the 52-week high for Pelthos Therapeutics Inc.?
What is the 52-week low for Pelthos Therapeutics Inc.?
What is Pelthos Therapeutics Inc. stock price today?
What was Pelthos Therapeutics Inc. stock price yesterday?
What is the PE ratio of Pelthos Therapeutics Inc.?
What is the Price-to-Book ratio of Pelthos Therapeutics Inc.?
What is the 50-day moving average of Pelthos Therapeutics Inc.?

Latest PTHS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.